tiprankstipranks
HUTCHMED (China) Limited (HK:0013)
:0013

Compare HUTCHMED (China) (0013) vs. Competitors

8 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
HUTCHMED (China)
HK$21.18
HK$20.29B
4.97
15.12%
10 Buy
0 Hold
1 Sell
Strong Buy
China Medical System Holdings
HK$14.20
HK$35.81B
19.33
96.05%
3 Buy
0 Hold
0 Sell
Strong Buy
Livzon Pharmaceutical Group
HK$30.94
HK$32.00B
11.61
12.86%
0 Buy
0 Hold
1 Sell
Moderate Sell
Shanghai Fosun Pharmaceutical (Group) Co
HK$19.63
HK$76.21B
14.15
50.30%
1 Buy
0 Hold
0 Sell
Moderate Buy
Hansoh Pharmaceutical Group Company Limited
HK$38.22
HK$231.43B
35.71
77.79%
7 Buy
0 Hold
0 Sell
Strong Buy
CanSino Biologics, Inc. Class H
HK$44.94
HK$13.47B
292.71
14.41%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:0013
HUTCHMED (China)
23.60
2.65
12.65%
HK:0867
China Medical System Holdings
14.39
7.31
103.33%
HK:1513
Livzon Pharmaceutical Group
29.40
4.35
17.37%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
20.02
6.66
49.87%
HK:3692
Hansoh Pharmaceutical Group Company Limited
38.58
16.87
77.71%
HK:6185
CanSino Biologics, Inc. Class H
32.72
4.32
15.21%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts